Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Medroxyprogest acetate (Cancer)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Medroxyprogesterone 200mg tablets
0803020H0AAADAD
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | 1,690 |
|
Medroxyprogesterone 100mg tablets
0803020H0AAACAC
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | 1,530 |
|
Medroxyprogesterone 400mg tablets
0803020H0AAAFAF
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | 490 |
|
Medroxyprogesterone 100mg/5ml oral liquid
0803020H0AAANAN
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Medroxyprogesterone 10mg/5ml oral liquid
0803020H0AAARAR
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Medroxyprogesterone 200mg/5ml oral suspension
0803020H0AAAQAQ
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Medroxyprogesterone 20mg/5ml oral suspension
0803020H0AAAPAP
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Medroxyprogesterone 250mg tablets
0803020H0AAAEAE
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Medroxyprogesterone 400mg/5ml oral liquid
0803020H0AAAKAK
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Medroxyprogesterone 500mg tablets
0803020H0AAAGAG
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Medroxyprogesterone 500mg/2.5ml inj vials
0803020H0AAABAB
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.